Dr John Ward on expanding HCV testing to achieve elimination goals

J.WardJ.Ward
BulletArticle
Infectious Diseases Liver disease & HCC RED 2023
共有する：
リンクをコピーする
Dr John Ward on expanding HCV testing to achieve elimination goals

As Director of the Coalition for Global Hepatitis Elimination of the Task Force for Global Health, Dr John Ward has deep experience in supporting hepatitis elimination strategies around the world. In this presentation at RED 2023, he focuses on the challenges around hepatitis C (HCV) elimination. This includes discussion of model programmes from around the world that demonstrate how changes in testing policies, laboratory methods, clinical practice, and community outreach improve access to testing and linkages to care.

共有する：
リンクをコピーする

同じトピックの記事

New HBV biomarkers support virus reduction efforts

PIVKA-II drives early detection of HCC in Vietnam

おすすめのトピック

SequencingRED 2020Rare Diseases
次のおすすめ記事
  • C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
  • C-Suite Perspectives, Leaders In Conversation, Management
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top